KDM4B
protein-codinglysine demethylase 4B, the group of Lysine demethylases|Tudor domain containing
Gene summary
Enables histone H3K36 demethylase activity and histone H3K9me2/H3K9me3 demethylase activity. Predicted to be involved in brain development; chromatin remodeling; and regulation of gene expression. Located in nucleoplasm. Implicated in autosomal dominant intellectual developmental disorder 65; breast cancer; colorectal cancer; malignant peripheral nerve sheath tumor; and stomach cancer. Biomarker of several diseases, including alopecia areata; lung cancer; medulloblastoma; prostate cancer; and stomach cancer. [provided by Alliance of Genome Resources, Jun 2026]
- JMJD2B
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~184.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0023657
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0000508
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0100038
Submitter: Illumina
Inheritance Pattern: AD
Disease ID:MONDO:0023657
Submitter: ClinGen
The *KDM4B* gene is located on chromosome 19 at 19p13.3 and is a histone demethylase that specifically demethylates 'Lys-9' of histone H3, thereby playing a role in histone code. The *KDM4B* gene was first reported in relation to intellectual developmental disorder, autosomal dominant 65 in 2020 (Duncan et al. 2020, PMID: 33232677). This disorder is characterized by global developmental delay, intellectual disability, language delays, structural brain anomalies, characteristic facial features, and clinodactyly.. Ten unique variants (4 missense, 4 insertion/deletion, 1 splice-site, 1 synonymous) that have been reported in 10 individuals from 2 publications are included in this curation (PMIDs: 33232677, 38270710). In seven of the ten individuals, variants were reported as de novo occurrences. The mechanism of pathogenicity appears to be loss of function. This gene-disease relationship is also supported by experimental evidence including biochemical function and two mouse models recapitulating the human phenotype (PMIDs: 35186950, 27023172, 33232677). In summary, there is strong evidence to support the relationship between *KDM4B* and Intellectual developmental disorder, autosomal dominant 65. Three years must elapse from the first proposal of the assertion to reach a definitive classification without any valid contradictory evidence. We will re-evaluate this gene-disease relationship at that time to determine if an upgraded classification of definitive is warranted. This classification was approved by the ClinGen Syndromic Disorders GCEP on the meeting date November 6th, 2024 (SOP Version 11).
Inheritance Pattern: AD
Disease ID:MONDO:0023657
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0023657
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision making, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to KDM4B variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_015015.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 7 | 59 | 5 | 72 | |
| missense | 2 | 4 | 298 | 33 | 337 | |
| nonsense | 3 | 8 | 1 | 12 | ||
| start loss | 1 | 1 | ||||
| frameshift | 5 | 8 | 2 | 15 | ||
| splice donor/acceptor (+/-2bp) | 1 | 8 | 9 | 18 | ||
| Total | 11 | 29 | 318 | 92 | 5 | 455 |
Highest pathogenic variant AF is 0.000025030826
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_055830.1 | 21 | MANE Select | |
| Ensembl | ENSP00000159111.3 | 21 | MANE Select | |
| RefSeq | NP_001357022.1 | 10 | Standard | |
| RefSeq | NP_001357023.1 | 9 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- DNA Repair
- Signal Transduction
- DNA Double-Strand Break Repair
- HDMs demethylate histones
- Chromatin modifying enzymes
Biological Process
- negative regulation of transcription by RNA polymerase II
- chromatin remodeling
- histone H3-K9 demethylation
- oxidation-reduction process
- histone H3-K36 demethylation
Molecular Function
- histone demethylase activity
- histone demethylase activity (H3-K9 specific)
- metal ion binding
- histone demethylase activity (H3-K36 specific)
Cellular Component
- nucleus
- nucleoplasm
- histone methyltransferase complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000159111
- Coding exons
- 21
- Length
- 184482
- Individuals with no LoFs
- 125717
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 8
- Defined
- 125725
- p
- 0.0000318
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 3.48 | 469 | 735 | 0.638 | 0.0000522 | 7054 |
| Missense (PolyPhen) | 69 | 187.01 | 0.36896 | 1599 | ||
| Synonymous | -0.645 | 353 | 338 | 1.04 | 0.0000280 | 2183 |
| Loss of Function | 6.27 | 4 | 53.5 | 0.0747 | 0.00000256 | 600 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.000029 | 0.000029 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000055 | 0.000053 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Histone demethylase that specifically demethylates 'Lys- 9' of histone H3, thereby playing a role in histone code. Does not demethylate histone H3 'Lys-4', H3 'Lys-27', H3 'Lys-36' nor H4 'Lys-20'. Only able to demethylate trimethylated H3 'Lys-9', with a weaker activity than KDM4A, KDM4C and KDM4D. Demethylation of Lys residue generates formaldehyde and succinate. {ECO:0000269|PubMed:16603238, ECO:0000269|PubMed:28262558}.;
Recessive Scores
- pRec
- 0.114
Intolerance Scores
- LoFtool
- 0.0736
- RVIS EVS
- -2.57
- RVIS percentile EVS
- 0.84
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.806
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |